BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calao M, Wilson JL, Spelman L, Billot L, Rubel D, Watts AD, Jemec GBE. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study. PLoS One 2018;13:e0200683. [PMID: 30040827 DOI: 10.1371/journal.pone.0200683] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Jfri A, Nassim D, O'Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol 2021;157:924-31. [PMID: 34037678 DOI: 10.1001/jamadermatol.2021.1677] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
2 Liy-Wong C, Kim M, Kirkorian AY, Eichenfield LF, Diaz LZ, Horev A, Tollefson M, Oranges T, Philips R, Chiu YE, Ghafari G, Arnold JD, Sprague J, Nguyen H, Wan S, Atenafu EG, Pope E, Hamilton J, Naik HB, Lara-Corrales I. Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients. JAMA Dermatol 2021;157:385-91. [PMID: 33625473 DOI: 10.1001/jamadermatol.2020.5435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Phan K, Charlton O, Smith SD. Global prevalence of hidradenitis suppurativa and geographical variation—systematic review and meta-analysis. biomed dermatol 2020;4. [DOI: 10.1186/s41702-019-0052-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 14.0] [Reference Citation Analysis]
4 Tzanetakou V, Stergianou D, Giamarellos-Bourboulis EJ. Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa. Expert Opin Drug Saf 2020;19:381-93. [PMID: 32098513 DOI: 10.1080/14740338.2020.1734560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and metabolic syndrome - systematic review and adjusted meta-analysis. Int J Dermatol 2019;58:1112-7. [PMID: 31148159 DOI: 10.1111/ijd.14500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Kucinskiene V, Jariene V, Valiukeviciene S. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania. Dermatology 2020;236:66-70. [PMID: 31940646 DOI: 10.1159/000505742] [Reference Citation Analysis]
7 Williams C, Hunt J, Kern JS, Dunn R. A casemix study of patients seen within an urban Aboriginal Health Service dermatology clinic over a five-year period. Australas J Dermatol 2021;62:331-5. [PMID: 34004028 DOI: 10.1111/ajd.13630] [Reference Citation Analysis]
8 Kjærsgaard Andersen R, Saunte SK, Jemec GBE, Saunte DM. Psoriasis as a comorbidity of hidradenitis suppurativa. Int J Dermatol 2019;59:216-20. [DOI: 10.1111/ijd.14651] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020;6:18. [PMID: 32165620 DOI: 10.1038/s41572-020-0149-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 56.0] [Reference Citation Analysis]
10 Schneider‐burrus S, Lux G, Linde K, Barbus S, Huss‐marp J, Tsaousi A, Wasem J, Wolff B, Sabat R. Hidradenitis suppurativa – prevalence analyses of German statutory health insurance data. J Eur Acad Dermatol Venereol 2021;35. [DOI: 10.1111/jdv.16783] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol 2020;183:990-8. [PMID: 32880911 DOI: 10.1111/bjd.19435] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
12 Zouboulis CC. The socioeconomic burden of hidradenitis suppurativa/acne inversa. Br J Dermatol 2019;181:7-8. [PMID: 31259406 DOI: 10.1111/bjd.17396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kok Y, Nicolopoulos J, Braue A, Kern JS, Varigos G, Dolianitis C. Measuring treatment response to adalimumab in hidradenitis suppurativa patients: An observational study. Australas J Dermatol 2020;61:292-4. [PMID: 32065658 DOI: 10.1111/ajd.13245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kim HB, Lim SY, Yoon CS, Kim KN. Reconstruction of bilateral inferomedial gluteal defects after resection of hidradenitis suppurativa with symmetrical keystone flaps designed parallel to relaxed skin-tension lines: A case report. Medicine (Baltimore) 2020;99:e19779. [PMID: 32243413 DOI: 10.1097/MD.0000000000019779] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tricarico PM, Boniotto M, Genovese G, Zouboulis CC, Marzano AV, Crovella S. An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis. Front Immunol 2019;10:892. [PMID: 31105704 DOI: 10.3389/fimmu.2019.00892] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 18.5] [Reference Citation Analysis]
16 Willems D, Charokopou M, Evers SMAA, Hiligsmann M. Early health economic modelling for a treatment candidate in hidradenitis suppurativa. J Med Econ 2020;23:1516-24. [PMID: 33084453 DOI: 10.1080/13696998.2020.1840181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wolk K, Brembach T, Šimaitė D, Bartnik E, Cucinotta S, Pokrywka A, Irmer M, Triebus J, Witte‐händel E, Salinas G, Leeuw T, Volk H, Ghoreschi K, Sabat R. Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*. Br J Dermatol 2021;185:164-76. [DOI: 10.1111/bjd.19795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
18 Pinter A, Kokolakis G, Rech J, Biermann MHC, Häberle BM, Multmeier J, Reinhardt M. Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors. Dermatol Ther (Heidelb) 2020;10:721-34. [PMID: 32500484 DOI: 10.1007/s13555-020-00401-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Kirsten N, Zander N, Augustin M. Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population. Arch Dermatol Res 2021;313:95-9. [PMID: 32322958 DOI: 10.1007/s00403-020-02065-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Alhawsawi EMF, Hariri GA, Alzuhayri RJ, Makhdoom Y. Knowledge about and determinants for diagnosing hidradenitis suppurativa by ministry of health primary healthcare physicians in Jeddah city 2019: An analytical cross-sectional study. J Family Med Prim Care 2020;9:1448-52. [PMID: 32509631 DOI: 10.4103/jfmpc.jfmpc_1151_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Patel KR, Lee HH, Rastogi S, Vakharia PP, Hua T, Chhiba K, Singam V, Silverberg JI. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 2020;83:737-44. [DOI: 10.1016/j.jaad.2019.11.068] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
22 Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jemec G. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 2021;35:50-61. [DOI: 10.1111/jdv.16677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 23.0] [Reference Citation Analysis]
23 Jemec GBE. Hidradenitis suppurativa in Korea. J Eur Acad Dermatol Venereol 2018;32:1625. [PMID: 30303307 DOI: 10.1111/jdv.15220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]